Kala Pharmaceuticals, Inc.
KALA
|
$6.4
-2.53%
4.24%
0
|
Health Technology
(0.0% 1d) (-18.8% 1m) (-57.3% 1y) (0.0% 2d) (-2.6% 3d) (-2.9% 7d) (-79.16% volume)
Earnings Calendar: 2024-02-29
Market Cap: $ 18,025,306
http://www.kalarx.com
Sec Filling | Patents | 136 employees
(US) Kala Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based Mucus Penetrating Particles, or MPP, technology, with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Watertown, MA.
eye diseases eye treatment
Drugs
Eysuvis (loteprednol etabonate)Inveltys (loteprednol etabonate)
add to watch list Paper trade email alert is off
Press-releases
KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-03-29 (Crawled : 12:00) - globenewswire.com
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
| Email alert
Add to watchlist
ALC | $78.36 -1.52% 25K
|
Health Technology
| Email alert
Add to watchlist
year update financial results
KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference
Published: 2024-02-26 (Crawled : 13:00) - globenewswire.com
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -0.57%
H: 6.16%
C: 3.04%
conference
KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference
Published: 2024-02-06 (Crawled : 13:00) - globenewswire.com
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -0.14%
H: 0.72%
C: 0.72%
conference life sciences
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2024-01-19 (Crawled : 21:00) - globenewswire.com
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
| Email alert
Add to watchlist
nasdaq grants
KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
ALC | $78.36 -1.52% 25K
|
Health Technology
|
| O: -1.43%
H: 1.41%
C: 0.29%
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -1.26%
H: 3.63%
C: 0.62%
update financial results
KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published: 2023-09-20 (Crawled : 20:00) - globenewswire.com
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -2.44%
H: 2.79%
C: 2.79%
nasdaq grants
KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference
Published: 2023-09-05 (Crawled : 12:00) - globenewswire.com
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -1.44%
H: 1.31%
C: -10.29%
conference global
Global $500+ Mn Neurotrophic Keratitis Markets, 2023-2028: Empowering Vision Health - Neurotrophic Keratitis Market on the Rise
Published: 2023-08-25 (Crawled : 17:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.32% 5.9K
|
Health Technology
|
| O: 0.67%
H: 0.37%
C: 0.26%
JNJ | News | $148.53 -0.69% 0.11% 67K
|
Health Technology
|
| O: 0.51%
H: 0.0%
C: 0.0%
ABBV | News | $168.67 0.52% 260K
|
Health Technology
|
| O: -0.11%
H: 0.44%
C: -0.22%
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -1.31%
H: 0.85%
C: 0.67%
BBIO | $25.03 -1.69% -1.76% 0
|
Health Technology
|
| O: 0.71%
H: 5.34%
C: 4.95%
health global market
KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-04 (Crawled : 12:00) - globenewswire.com
ALC | $78.36 -1.52% 25K
|
Health Technology
|
| O: 1.53%
H: 0.0%
C: 0.0%
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -2.36%
H: 1.38%
C: -2.69%
update financial results
KALA BIO to Participate in Upcoming Investor Conferences in August
Published: 2023-08-02 (Crawled : 20:00) - globenewswire.com
KALA | $6.4 -2.53% 4.24% 0
|
Health Technology
|
| O: -1.91%
H: 0.0%
C: 0.0%
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 50% | 50% |
Top 10 Gainers
CSSE 4 | $0.299 96.32% 7M
|
Consumer Services
BRFH 4 | $1.99 80.91% 13M
|
Manufacturing
BOF | $1.915 63.68% 620K
|
AMST | $3.13 56.5% 500K
|
Technology Services
ACON | $0.3595 24.83% 3.5M
|
n/a
CDTX | News | $14.57 18.55% 330K
|
Health Technology
ULBI M | $10.12 15.92% 120K
|
Producer Manufacturing
LRHC | $1.79 11.88% 3K
|
n/a
AIXI | $1.34 8.94% 42K
|
n/a
TRU | $74.475 8.44% 100K
|
Technology Services
Last 48 Hours Insiders Buying
MNSB P 1470 | $15.89 -2.87% -3.02% 0
|
Finance
|
12:00
RKT P 347 | $12.55 -0.63% 0.88% 0
|
Finance
|
22:30
NWFL | News | $24.21 0.42% 1.99% 0
|
Finance
|
22:00
TGEN P 10000 | $0.68 20K
|
Utilities
|
20:01
RMCF | $3.55 0.28% 0.28% 0
|
Consumer Non-Durables
|
20:10